Serum adiponectin and leptin as predictors of the presence and degree of coronary atherosclerosis

Coronary Artery Disease

Volumn 22, Issue 4, 2011, Pages 264-269

  Hasan Ali, Hosam ^a,b   Abd El Mottaleb, Nashwa A ^a   Hamed, Hosny B ^a   Abd Elsayed, Alaa ^a  

^a Assiut University Faculty of Medicine   (Egypt)

^b ASSIUT UNIVERSITY   (Egypt)

Author keywords

Adiponectin; coronary atherosclerosis; extent; leptin; pattern; severity

Indexed keywords

ADIPONECTIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LEPTIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGE; ANGIOCARDIOGRAPHY; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; FEMALE; GLUCOSE BLOOD LEVEL; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; UNSTABLE ANGINA PECTORIS; WAIST HIP RATIO;

ADIPONECTIN; ADULT; AGED; CASE-CONTROL STUDIES; CORONARY ARTERY DISEASE; FEMALE; HUMANS; LEPTIN; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; SEVERITY OF ILLNESS INDEX;

EID: 79955634915     PISSN: 09546928     EISSN: None     Source Type: Journal    
DOI: 10.1097/MCA.0b013e3283452431     Document Type: Article

References (30)

1. Matsuda M, Shimomura I, Sata M, Arita Y, Nishida M, Maeda N, et al. Role of adiponectin in preventing vascular stenosis: The missing link of adipovascular axis. J Biol Chem 2002; 277:37487-37491.
2. Ouchi N, Kihara S, Arita Y, Nishida M, Matsuyama A, Okamoto Y, et al. Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages. Circulation 2001; 103:1057-1063. (Pubitemid 32200177)
3. Arita Y, Kihara S, Ouchi N, Maeda K, Kuriyama H, Okamoto Y, et al. Adipocyte-derived plasma protein adiponectin acts as a platelet-derived growth factor-BB-binding protein and regulates growth factor induced common postreceptor signal in vascular smooth muscle cell. Circulation 2002; 105:2893-2898. (Pubitemid 34666104)
4. Jaleel F, Jaleel A, Aftab J, Rahman MA. Relationship between adiponectin, glycemic control and blood lipids in diabetic type 2 postmenopausal women with and without complication of ischemic heart disease. Clin Chim Acta 2006; 370:76-81. (Pubitemid 44096945)
5. Nakamura Y, Shimada K, Fukuda D, Shimada Y, Ehara S, Hirose M, et al. Implications of plasma concentrations of adiponectin in patients with coronary artery disease. Heart 2004; 90:528-533. (Pubitemid 38530170)
6. Kubota N, Terauchi Y, Yamauchi T, Kubota T, Moroi M, Matsui J, et al. Disruption of adiponectin causes insulin resistance and neointimal formation. J Biol Chem 2002; 277:25863-25866. (Pubitemid 34967064)
7. Hara K, Yamauchi T, Imai Y, Manabe I, Nagai R, Kadowaki T. Reduced adiponectin level is associated with severity of coronary artery disease. Int Heart J 2007; 48:149-153. (Pubitemid 46592753)
8. Zimmet P, Hodge A, Nicolson M, Staten M, de Courten M, Moore J, et al. Serum leptin concentration, obesity and insulin resistance in Western Samoans: Cross-sectional study. BMJ 1996; 313:965-969. (Pubitemid 26385521)
9. Loffreda S, Yang SQ, Lin HZ, Karp CL, Brengman ML, Wang DJ, et al. Leptin regulates proinflammatory immune responses. FASEB J 1998; 12:57-65. (Pubitemid 28060271)
10. Maingrette F, Renier G. Leptin increases lipoprotein lipase secretion by macrophages: Involvement of oxidative stress and protein kinase C. Diabetes 2003; 52:2121-2128. (Pubitemid 36919807)
11. Lundasen T, Liao W, Angelin B, Rudling M. Leptin induces the hepatic high density lipoprotein receptor scavenger receptor B type I (SR-BI) but not cholesterol 7a-hydroxylase (Cyp7a1) in leptin-deficient (ob/ob) mice. J Biol Chem 2003; 278:43224-43228. (Pubitemid 37345941)
12. Momin AU, Melikian N, Shah AM, Grieve DJ,Wheatcroft SB, John L, et al. Leptin is an endothelial independent vasodilator in humans with coronary artery disease: Evidence for tissue specificity of leptin resistance. Eur Heart J 2006; 27:2294-2299. (Pubitemid 44453572)
13. Vecchione C, Maffei A, Colella S, Aretini A, Poulet R, Frati G, et al. Leptin effect on endothelial nitric oxide is mediated through Akt-endothelial nitric oxide synthase phosphorylation pathway. Diabetes 2002; 51:168-173. (Pubitemid 34517994)
14. Wolk R, Deb A, Caplice NM, Somers VK. Leptin receptor and functional effects of leptin in human endothelial progenitor cells. Atherosclerosis 2005; 183:131-139. (Pubitemid 41416831)
15. O'Rourke L, Gronning LM, Yeaman SJ, Shepherd PR. Glucosedependent regulation of cholesterol ester metabolism in macrophages by insulin and leptin. J Biol Chem 2002; 277:42557-42562. (Pubitemid 35285623)
16. Friedewald WT, Levy R, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18:499-502.
17. Bogaty P, Brecker SJ,White SE, Stevenson RN, el-Tamimi H, Balcon R, et al. Comparison of coronary angiographic findings in acute and chronic first presentation of ischemic heart disease. Circulation 1993; 87:1938-1946. (Pubitemid 23165637)
18. Scanlon PJ, Faxon DP, Audet AM, Carabello B, Dehmer GJ, Eagle KA, et al. ACC/AHA guidelines for coronary angiography: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on Coronary Angiography), developed in collaboration with the Society for Cardiac Angiography and Interventions. J Am Coll Cardiol 1999; 33:1756-1824.
19. Von Eynatten M, Schneider JG, Humpert PM, Kreuzer J, Kuecherer H, Katus HA, et al. Serum adiponectin levels are an independent predictor of the extent of coronary artery disease in men. J Am Coll Cardiol 2006; 47:2124-2126.
20. Lim HS, Tayebjee MH, Tan KT, Patel JV, Macfadyen RJ, Lip GY. Serum adiponectin in coronary heart disease: Ethnic differences and relation to coronary artery disease severity. Heart 2005; 91: 1605-1606. (Pubitemid 41697608)
21. Chen H, Montagnani M, Funahashi T, Shimomura I, Quon MJ. Adiponectin stimulates production of nitric oxide in vascular endothelial cells. J Biol Chem 2003; 278:45021-45026. (Pubitemid 37377262)
22. Wallace AM, McMahon AD, Packard CJ, Kelly A, Shepherd J, Gaw A, et al. Plasma leptin and the risk of cardiovascular disease in the west of Scotland coronary prevention study (WOSCOPS). Circulation 2001; 104:3052-3056. (Pubitemid 34014056)
23. Wolk R, Berger P, Lennon RJ, Brilakis ES, Johnson BD, Somers VK. Plasma leptin and prognosis in patients with established coronary atherosclerosis. J Am Coll Cardiol 2004; 44:1819-1824. (Pubitemid 39424081)
24. Matsuda K, Teragawa H, Fukuda Y, Nakagawa K, Higashi Y, Chayama K. Leptin causes nitric-oxide independent coronary artery vasodilation in humans. Hypertens Res 2003; 26:147-152. (Pubitemid 36372333)
25. Couillard C, Lamarche B, Mauriege P, Cantin B, Dagenais GR, Moorjani S, et al. Leptinemia is not a risk factor for ischemic heart disease in men: Prospective results from the Quebec Cardiovascular Study. Diabetes Care 1998; 21:782-786. (Pubitemid 28487071)
26. Piemonti L, Calori G, Mercalli A, Lattuada G, Monti P, Garancini MP, et al. Fasting plasma leptin, tumor necrosis factor-a receptor 2, and monocyte chemoattracting protein 1 concentration in a population of glucose-tolerant and glucose-intolerant women: Impact on cardiovascular mortality. Diabetes Care 2003; 26:2883-2889. (Pubitemid 37205563)
27. Cooke JP, Oka RK. Does leptin cause vascular disease? Circulation 2002; 106:1904-1905. (Pubitemid 35176291)
28. Li L, Mamputu JC,Wiernsperger N, Renier G. Signaling pathways involved in human vascular smooth muscle cell proliferation and matrix metalloproteinase-2 expression induced by leptin: Inhibitory effect of metformin. Diabetes 2005; 54:2227-2234. (Pubitemid 40911288)
29. Quehenberger P, Exner M, Sunder-Plassmann R, Ruzicka K, Bieglmayer C, Endler G, et al. Leptin induces endothelin-1 in endothelial cells in vitro. Circ Res 2002; 90:711-718. (Pubitemid 34640891)
30. Wolk R, Somers VK. Leptin and vascular function: Friend or foe? Eur Heart J 2006; 27:2263-2265. (Pubitemid 44453564)